oxybutynin has been researched along with Breast Pain in 1 studies
oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.
Excerpt | Relevance | Reference |
---|---|---|
"Mean number of bleeding/spotting episodes was comparable across groups for both reference periods, but bleeding/spotting episodes were shorter for the EE/GSD patch than the EE/NGMN patch during reference period 1 (5." | 2.80 | A comparison of bleeding patterns and cycle control using two transdermal contraceptive systems: a multicenter, open-label, randomized study. ( Gruber, D; Lanius, V; Merz, M; Serrani, M; Skřivánek, A, 2015) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gruber, D | 1 |
Skřivánek, A | 1 |
Serrani, M | 1 |
Lanius, V | 1 |
Merz, M | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Transdermal Contraception Patch: EU Cycle Control Study Versus EVRA[NCT00984789] | Phase 3 | 393 participants (Actual) | Interventional | 2009-05-31 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 trial available for oxybutynin and Breast Pain
Article | Year |
---|---|
A comparison of bleeding patterns and cycle control using two transdermal contraceptive systems: a multicenter, open-label, randomized study.
Topics: Adolescent; Adult; Amenorrhea; Austria; Contraceptive Agents, Female; Czech Republic; Drug Combinati | 2015 |